#1 Clinical Trials Search in Europe

Fusidic Acid

Fusidic acid, a potent antibiotic, is being studied in several clinical trials for its effectiveness in treating various medical conditions. These trials aim to evaluate its potential in managing infections, skin conditions, and other health issues. This article summarizes the key findings from recent clinical trials involving fusidic acid, providing insights into its possible applications and benefits.

Table of Contents

What is Fusidic Acid?

Fusidic acid is an antibiotic medication used to treat various bacterial infections. It’s also known by several other names, including sodium fusidate, CEM-102, and ARV-1801[1][2]. This drug works by stopping bacteria from growing and multiplying, helping your body’s immune system to fight off the infection.

Conditions Treated with Fusidic Acid

Fusidic acid is used to treat a variety of bacterial infections, including:

  • Skin and soft tissue infections: Such as impetigo (a contagious skin infection that causes red sores), and other skin infections[3]
  • Bone and joint infections: Particularly those caused by Staphylococcus bacteria[1]
  • Eye infections: Such as blepharitis (inflammation of the eyelids)[4]
  • Acute bacterial skin and skin structure infections (ABSSSI): These are serious skin infections that often require antibiotic treatment[5]

Forms and Administration

Fusidic acid comes in various forms, depending on the type of infection being treated:

  • Oral tablets: For treating internal infections like bone and joint infections[1]
  • Topical cream or ointment: For treating skin infections[6]
  • Eye drops: For treating eye infections[4]

The dosage and duration of treatment can vary depending on the specific condition being treated and the severity of the infection. Always follow your healthcare provider’s instructions carefully.

Effectiveness of Fusidic Acid

Fusidic acid has been shown to be effective in treating various bacterial infections. For example:

  • In treating impetigo, a study found that fusidic acid cream was effective in clearing the infection[3]
  • For bone and joint infections, fusidic acid is being studied as a long-term treatment option, especially for patients who can’t use other antibiotics[1]
  • In treating skin infections associated with cancer treatments, fusidic acid cream was compared to other treatments for its effectiveness[6]

Ongoing Research and Potential New Uses

Researchers are continually studying fusidic acid to explore its potential in treating other conditions:

  • Cystic fibrosis-related lung infections: A study is investigating whether adding oral fusidic acid to standard treatments can improve outcomes for patients with cystic fibrosis who experience lung infections[2]
  • Complicated skin infections in diabetic patients: Researchers are exploring whether fusidic acid cream can help improve wound healing in diabetic foot ulcers[7]
  • Leishmaniasis: This is a parasitic disease, and scientists are studying whether fusidic acid cream can help improve treatment outcomes when combined with standard therapy[8]

Side Effects and Precautions

Like all medications, fusidic acid can cause side effects, although not everyone experiences them. Common side effects may include:

  • Skin irritation or rash (when using topical forms)
  • Nausea or stomach discomfort (with oral forms)
  • Eye irritation (with eye drops)

It’s important to use fusidic acid as prescribed by your healthcare provider. Overuse or misuse of antibiotics can lead to antibiotic resistance, where bacteria become harder to treat with available medications.

Always inform your healthcare provider about any other medications you’re taking, as fusidic acid can interact with certain drugs. If you experience any severe side effects or allergic reactions, seek medical attention immediately.

Condition Study Type Fusidic Acid Form Key Findings/Objectives
Staphylococcal Bone or Joint Infections Open-label, single-arm Oral Evaluating safety and effectiveness for chronic antibiotic suppressive therapy
Hypertrophic Scars and Keloids Randomized, placebo-controlled Topical cream Assessing prevention of scarring after central venous catheter removal
Cutaneous Leishmaniasis Randomized, controlled Topical cream Evaluating combination with standard treatment for improved outcomes
Impetigo Randomized, placebo-controlled Topical cream Comparing clinical and bacteriological efficacy with placebo
Acute Bacterial Skin and Skin Structure Infections Randomized, double-blind Oral Comparing efficacy with linezolid for early clinical response
Diabetic Foot Ulcers Randomized, controlled Topical ointment Comparing healing effects with honey and hydrogel products
Cancer Treatment-Related Skin Rash Randomized, open-label Topical cream Evaluating management of Tarceva-associated rash in lung cancer patients

FAQ

  • What is fusidic acid? Fusidic acid is an antibiotic medication that is effective against various bacterial infections, particularly those caused by Staphylococcus bacteria. It works by inhibiting bacterial protein synthesis, thus stopping the growth and spread of bacteria.
  • In which medical conditions is fusidic acid being studied? Based on the clinical trials data, fusidic acid is being studied for conditions such as bone and joint infections, skin infections, cystic fibrosis-related pulmonary exacerbations, and as a potential treatment for skin rashes associated with cancer treatments.
  • How is fusidic acid administered in these trials? Fusidic acid is administered in various forms depending on the study. It can be given orally as tablets, applied topically as a cream or ointment, or used in combination with other medications.
  • Are there any side effects associated with fusidic acid use? While specific side effects are not detailed in the provided trial data, as with any medication, fusidic acid may have potential side effects. These are typically monitored and recorded as part of the clinical trials process to ensure patient safety.
  • How long do the clinical trials for fusidic acid typically last? The duration of clinical trials varies depending on the condition being studied and the trial design. From the available data, trials can last anywhere from a few weeks to several months, with some studies following patients for up to 24 months.

Ongoing Clinical Trials on Fusidic Acid

  • Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study on Antibiotic Treatment for Hip and Knee Joint Infections Using Linezolid, Fusidic Acid, and Rifampicin

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France

Glossary

  • Acute Bacterial Skin and Skin Structure Infections (ABSSSI): A type of bacterial infection affecting the skin and underlying tissues, often requiring antibiotic treatment.
  • Cystic Fibrosis Pulmonary Exacerbation: A worsening of lung symptoms in patients with cystic fibrosis, often requiring additional treatment.
  • Dounis Classification: A system used to categorize and assess the severity of diabetic foot ulcers.
  • Early Clinical Response (ECR): A measure used in clinical trials to assess the initial effectiveness of a treatment, typically within the first few days of administration.
  • Fusidic Acid: An antibiotic medication effective against various bacterial infections, particularly those caused by Staphylococcus bacteria.
  • Hypertrophic Scars: Raised, thickened scars that develop after skin injury, often more prominent than normal scars.
  • Impetigo: A common and highly contagious bacterial skin infection that mainly affects infants and children.
  • Keloids: Overgrown scar tissue that extends beyond the original injury site, often appearing as smooth, hard growths on the skin.
  • Optimized Background Therapy (OBT): A customized treatment regimen that includes the best available medications for a patient's specific condition.
  • Staphylococcal Bone or Joint Infections: Infections of the bone or joint caused by Staphylococcus bacteria, often requiring long-term antibiotic treatment.

References

  1. https://clinicaltrials.gov/study/NCT02569541
  2. https://clinicaltrials.gov/study/NCT05641298
  3. https://clinicaltrials.gov/study/NCT00986856
  4. https://clinicaltrials.gov/study/NCT03105505
  5. https://clinicaltrials.gov/study/NCT02570490
  6. https://clinicaltrials.gov/study/NCT00718315
  7. https://clinicaltrials.gov/study/NCT03816618
  8. https://clinicaltrials.gov/study/NCT06695143